⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 54 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 54 minutes ago
🛡️ EUSW
🇬🇧
🧸 Product BE BG SE April 10, 2020

BRP — Can-am Spyder RT

Three-wheeled motor vehicle/motorcycle.

Risk level
Serious risk
Type
Injuries
Category
Motor vehicles

Hazard: The strength of the support of the brake mechanism is insufficient. Consequently, it could break in the event of an emergency, leading to a loss of braking capacity and increasing the risk of an accident.

Origin
Canada

⚖️ Actions ordered by authorities

  • Measures ordered by economic operators (to: Importer) Recall of the product from end users
🗄
Archived (older alert)
This alert was reported 2345 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
117 days in total
May 17, 2026 September 11, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? This is about a three-wheeled motor vehicle called the Can-am Spyder RT made by BRP. The brake support part may not be strong enough.

What's happening? The brake support could break in an emergency. This could make the brakes stop working and raise the chance of a crash.

Does this affect me? If you own or ride a Can-am Spyder RT in Belgium, Bulgaria, or Sweden, this could affect you.

What should I do? Stop using the vehicle and contact a BRP dealer or mechanic right away. Ask your doctor or pharmacist if you need help with other safety steps.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Brand(s) / product name(s)
BRP
Agency-published detail

Risk level: Serious risk · Type: Injuries · Category: Motor vehicles · Hazard: The strength of the support of the brake mechanism is insufficient. Consequently, it could break in the event of an emergency, leading to a loss of braking capacity and increasing the risk of an accident. · Origin: Canada

First published
April 10, 2020
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10001013

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this product recall alert about?
BRP — Can-am Spyder RT. Risk level: Serious risk · Type: Injuries · Category: Motor vehicles · Hazard: The strength of the support of the brake mechanism is insufficient. Consequently, it could break in the event of an emergency, leading to a loss of braking capacity and increasing the risk of an accid...
When was this alert issued?
This alert was issued on April 10, 2020 by EU Safety Gate.
Which countries are affected?
The alert applies to the following countries: Belgium, Bulgaria, and Sweden.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you have this product at home, stop using it and return it to the point of purchase for a refund. Keep the receipt if you have one — most retailers refund without it for safety recalls.
Where can I find the official notice?
The full official notice is published on ec.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.